Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.

@article{Pawluski2009NeonatalSP,
  title={Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.},
  author={Jodi Pawluski and L A M Galea and Ursula M Brain and Michael P Papsdorf and Tim F Oberlander},
  journal={Pediatrics},
  year={2009},
  volume={124 4},
  pages={e662-70}
}
OBJECTIVE This study investigated neonatal S100B levels as a biomarker of prenatal selective serotonin reuptake inhibitor (SSRI) exposure. METHODS Maternal (delivery; N = 53) and neonatal (cord; N = 52) serum S100B levels were compared between prenatally SSRI-exposed (maternal, N = 36; neonatal, N = 37; duration: 230 +/- 71 days) and nonexposed (maternal, N = 17; neonatal, N = 15) groups. Measures of maternal depression and anxiety symptoms were assessed during the third trimester (33-36… CONTINUE READING